The WMS has provided advice for people with neuromuscular disorders, and their healthcare providers since the start of the COVID-19 pandemic. This is a document aiming to answer questions regarding the newly developed vaccines against Coronavirus SARS-CoV2 asked by people with neuromuscular disorders. This is a rapidly developing field, and the WMS will keep this advice in regular review.
Disclaimer: WMS members have contributed to the translation of the original document into various languages. WMS assumes that all the translated content is true and accurate to the English original.
Published on 28 February 2021.